Article
Optimized detection of germ cell neoplasia in situ in contralateral biopsy reduces the risk of second testis cancer
16 May 2022
Abstract excerpt
OBJECTIVE: To evaluate whether optimized and standardized diagnostic procedures would improve detection of germ cell neoplasia in situ (GCNIS) in the contralateral testis of patients with testicular germ cell tumour (TGCT) and decrease the rate of metachronous tumours, which in a nationwide Danish study was estimated to be 1.9%. PATIENTS AND METHODS: This was a retrospective analysis of outcomes in 655 patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
